Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stenoparib + Carboplatin + Eribulin in BRCA-Related Cancers
NCT02396433Phase 2Withdrawn
- Sponsor
- UT Health San Antonio
- Start
- Apr 2015
- Primary completion
- Apr 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of stenoparib in breast cancer, ovarian cancer, malignant solid tumor, sponsored by UT Health San Antonio. Planned start Apr 2015; status: withdrawn.
02
Drugs
stenoparib
03
Conditions
breast cancerovarian cancermalignant solid tumor
Beyond the preview
Go deeper on NCT02396433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02396433.